BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Drug Information for Everyone

Active substance manufacturer

Application for reporting of the manufacturing sites of the active substances actually used to manufacture the medicinal product.

Result reports of clinical trials

The new portal, released on 11 June 2024, is to be used in expansion stage 1 for initial sub­missions in accordance with Section 42b AMG under the respon­sibility of the BfArM (§ 77 AMG).

Variation submission

Application for sending variation notifications according to § 29 AMG and notifications. Variations must be submitted exclusively via the CESP portal from 26 October 2023.

Batch release

Pharmaceutical companies can use this application to submit batch release applications pursuant to section 32 of the AMG for products that are subject to mandatory state batch testing.

Pharmaceutical brokers

The publicly accessible list of pharmaceutical brokers (in German) has been updated.

PharmNet.Bund website with new design

2024.05.28

A revised version of the PharmNet.Bund portal has been online since 28 May 2024.
What's new? In addition to a more modern design, a service area has been created that centralises all manuals and FAQ on the PharmNet.Bund applications as well as all information on the topic of "Access and user authorisation". In addition, the website is now also optimised for use on mobile devices.

The Drug Information Portal of the Bund (Federal Government) and the Laender (States)

The portal PharmNet.Bund provides information of the competent authorities about drugs.

Public

The information system contains administrative data concerning the authorisation of drugs as well as Summary of Product Characteristics (SPCs) and Patient Information Leaflets (PILs).

Read more

Companies

Pharmaceutical companies and wholesaler are able to record their data and submit it online to the federal authorities.

Read more

National authorities

Staff members of the federal authorities are able to research and record national data online. The applications for national authorities are only available in German.

Read more

PharmNet.Bund applications

Drug information system

In the PharmNet.Bund drug information system, in addition to administrative data concerning the authorisation of drugs, further information such as patient information leaflets can be searched free of charge.

Read more

Supply shortages

The information on reported supply shortages comes directly from the pharmaceutical entrepreneur and is supplemented by data from the Medicinal Product and Application Database (AmAnDa).

Read more

Batch release

Holder of marketing authorizations for medicinal products are able to submit batch release applications pursuant to section 32 of the German Medicinal Products Act (Arzneimittelgesetz) electronically by using this portal.

Read more

Product information texts

Pursuant to Sections 11 sub-section 1a and 11a sub-section 3 of the Medicinal Products Act (AMG), the submission of the current product information texts (Summary of Product Characteristics (SmPC) and Package Leaflet (PIL) is required.

Read more

Our services for you

Service and support

myPharmNet

Access for pharmaceutical companies and authorities for applications for the submission, authorisation and registration of drugs.

Login

Please note

Use of the PharmNet name is made possible through the friendly approval of Cerner Deutschland GmbH that - as a provider for healthcare information technology solutions - offers software solutions for pharmaceutical management in hospital pharmacies under this trademark. BfArM and Cerner Deutschland GmbH are not involved in a business relationship.

PharmNet.Bund.de is a cooperative project of the German regulatory authorities – Federal Institute for Drugs and Medical Devices (BfArM), the Paul-Ehrlich-Institut (PEI) and the Federal Office of Consumer Protection and Food Safety (BVL) – together with the Robert Koch Institute (RKI). The project will be implemented in close cooperation with the competent authorities of the Laender coordinated by the Central Authority of the Laender for Health Protection with regard to Medicinal Products and Medical Devices (ZLG).